A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To

Status:
Completed

Trial end date:
2006-06-01

Target enrollment:

Participant gender:

To measure the level of drug in nasal tissue and blood after taking a single 2g dose or 500mg tablets for up to 3 days.

Phase 2

Pfizer

Azithromycin